Category Archives: Uncategorized

Doctors Without Borders contests Pfizer’s patent on pneumonia vaccine

Pfizer has come under fire for holding exclusive patent rights that bars competition on its pneumonia vaccine worldwide, which is being challenged in patent litigations in several countries, an aid group said Monday. Doctors Without Borders will challenge Pfizer in … Continue reading

Posted in Uncategorized, Vaccines, Patent Opposition, Patent examination system, Patent | Leave a comment

Rethinking IP in the TPP: Canadian Government Plays Key Role in Suspending Unbalanced Patent and Copyright Rules

Source: http://www.michaelgeist.ca/2017/11/rethinking-ip-in-the-tpp/ Years of disappointment in trade negotiations have left many Canadian intellectual property watchers hoping for the best, but expecting the worst when it comes to the IP provisions in trade deals. In earlier talks, Canadian negotiators would often advocate … Continue reading

Posted in Biologics/Biosimilars, Data Exclusivity, Patent Term Extension, TPP, TRIPS, TRIPS plus, Uncategorized | Leave a comment

The Trans-Pacific Partnership is back: experts respond

Source: The Conversation The latest incarnation of the Trans-Pacific Partnership (TPP) is said to have “fewer bad bits”. But as our experts point out below, there’s still a great deal wrong with, or missing from, the regional free trade agreement. The new … Continue reading

Posted in ISDS, TPP, Uncategorized | Leave a comment

THERE IS ONLY ONE SURE WAY TO FIX THE HEPATITIS C EPIDEMIC

BY TAHIR AMIN The opioid crisis has triggered immense tragedy, touching almost every community in America and creating complex healthcare problems, including a rise in chronic infections transmitted through injection drug use. New hepatitis C infections are at a 15-year … Continue reading

Posted in Hepatitis C, Uncategorized | Leave a comment

Time for costly medicine monopolies to go from TPP trade talks

Source: Conversation.com |November 9, 2017 Negotiators from 11 countries have been racing to resurrect the near-dead Trans-Pacific Partnership Agreement before the Asia-Pacific Economic Cooperation (APEC) summit this weekend. The latest plan to get the controversial trade deal up and running … Continue reading

Posted in Biologics/Biosimilars, Data Exclusivity, Patent, TPP, Uncategorized | Leave a comment

Patient groups march for access to medicines in South Africa

Source: MSF Access Finalise the draft policy and amend laws to save lives, activists tell dti PRETORIA – Today, more than 1,000 members of the Fix the Patent Laws Coalition (FTPL) will march to the Department of Trade and Industry … Continue reading

Posted in Uncategorized | Leave a comment

Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group

Source: Bloomberg Gilead Sciences Inc.’s U.S. patents on the blockbuster $84,000 hepatitis C treatment Sovaldi were challenged by a consumer group that’s battled the drugmaker around the world over the pricing.  The Initiative for Medicines, Access & Knowledge, a nonprofit focused on … Continue reading

Posted in Cancer, Evergreening, Hepatitis C, Patent, Uncategorized | Leave a comment